Combination of Local Ablative Therapy and Continuation of Immune Checkpoint Inhibitor (ICI) Therapy Provides Durable Treatment Response Past Oligometastatic Progression in NSCLC: A Case Report

Combination of Local Ablative Therapy and Continuation of Immune Checkpoint Inhibitor (ICI) Therapy Provides Durable Treatment Response Past Oligometastatic Progression in NSCLC: A Case Report

Adenosquamous carcinoma is a rare type of non-small cell lung cancer associated with advanced disease and poor prognosis. There is limited data for the management of mixed histology disease in elderly or frail patients. A 79-year-old woman with no smoking history presented with a right upper lobe lu...

Full description

Bibliographic Details
Main Authors: Cassia R. Griswold, Katie Kerrigan, Shiven B. Patel
Format: Article
Language:English
Published: Karger Publishers 2019-11-01
Series:Case Reports in Oncology
Subjects:
oligometastatic disease
local ablative therapy
immunotherapy
adenosquamous nsclc
elderly patient
Online Access:https://www.karger.com/Article/FullText/504473

Internet

https://www.karger.com/Article/FullText/504473

Similar Items